|
|
| (11) | Number of the document | |
| (68) | Number of the document | 3880197 |
| (21) | Application number for Supplementary Protection Certificate | PA 2025 543 |
| (22) | Date of filing the application | 2025-12-10 |
| (41) | Date of publication of the application | 2026-01-12 |
| Date of publication of SPC | ||
| (24) | Date of coming into effect of SPC |
| (71) |
Vertex Pharmaceuticals Incorporated ,
50 Northern Avenue, Boston, MA 02210,
US
|
| (73) |
Vertex Pharmaceuticals Incorporated ,
50 Northern Avenue, Boston, MA 02210,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/25/1943, 2025-06-30 |
| (95) | (a) vanzakaftoro arba jo farmaciniu požiūriu priimtinos druskos derinys, pageidautina kalcio druska, (b) tezakaftoras arba jo farmaciniu požiūriu priimtina druska ir (c) deutivakaftoras arba jo farmaciniu požiūriu priimtina druska |
| SPC application published |